ASGCT News

Enjoy the Final Day of #ASGCT2024!

Fill out our five-minute evaluation to let us know how we did! | May 11, 2024

Today, hear from our final oral abstract presenters and symposia speakers to close out the 27th Annual Meeting.

Read Full Story

Today: Global Outreach Committee Symposium, Final Fireside Chat, More Abstracts

Miss a session? Watch on demand for 30 days. | May 10, 2024

Later this morning, help us recognize our Outstanding New Investigator Award recipients!

Read Full Story

ASGCT Announces Joseph C. Glorioso, PhD, as Incoming Editor-in-Chief of Molecular Therapy

ASGCT & Molecular Therapy | May 09, 2024

Glorioso, a trailblazing gene therapy researcher and founding member of ASGCT, will assume the role on January 1, 2025.

Molecular Therapy

Read Full Story

Diversity, Equity, and Inclusion Within Gene and Cell Therapy: Where Does It Stand?

Christina Fuentes, PhD | May 09, 2024

Watch the DEI Committee's symposium on developing CGTs with a DEI-forward approach on the virtual platform if you missed it!

Annual Meeting 2024

Read Full Story

Hear from Drs. Beverly Davidson, Philip Gregory During Today's George Stam Lecture

Miss a session? Watch on demand for 30 days. | May 09, 2024

We're also looking forward to more symposia and oral abstracts, the second day of the Career Fair, and the Women in Gene + Cell Therapy reception.

Annual Meeting 2024

Read Full Story

Attend the Presidential Symposium and Visit the Exhibit Hall Today!

Miss a session? Watch on the virtual platform for 30 days. | May 08, 2024

#ASGCT2024 Day Two: The Exhibit Hall Opens at Noon

Annual Meeting 2024

Read Full Story

Welcome to the First Day of the 27th Annual Meeting!

Register for a half-day Workshop! | May 07, 2024

Register for a Workshop, watch the first oral abstract presentations, and hear from recipients of the Founders, Catalyst, and Mendell Awards. 

Annual Meeting 2024

Read Full Story

What To Know Before #ASGCT2024

Prepare for 4+ days of the latest CGT research, networking, and more. | May 06, 2024

We hope you're looking forward to the 27th Annual Meeting! Below you'll find important information that will help you prepare.

Annual Meeting 2024

Read Full Story

Read the Late-Breaking Abstracts Ahead of #ASGCT2024

Preview them before the Annual Meeting | May 03, 2024

ASGCT's late-breaking abstracts will be presented from Wednesday, May 8 through Friday, May 10.

Annual Meeting 2024

Read Full Story

ASGCT Announces New Board Members at 27th Annual Meeting

May 02, 2024

The incoming members of the Board of Directors will assume their roles on June 1, 2024.

Read Full Story

ASGCT 2024 Abstract Highlights with Chris Leidli, Emily Walsh Martin, and Lynnea Olivarez

Listen now! | April 23, 2024

Listen to a preview of the most intriguing and promising abstracts at #ASGCT2024.

Annual Meeting 2024

Read Full Story

Now Available: 27th Annual Meeting Abstracts

View the abstracts in our searchable module | April 22, 2024

Read the most innovative science in the field, with 1,800 pieces of original research—13% more than last year!

Annual Meeting 2024

Read Full Story

CMC Strategy with Susan D'Costa, PhD—The Issue

Listen now on the ASGCT Podcast Network! | April 16, 2024

"Geek out" with Susan and Emily on the intricacies of defining your CMC strategy and ready yourselves for a tour-de-force of analytical and process development for viral vectors.

Podcasts

Read Full Story

Prenatal Delivery of a Therapeutic Antisense Oligonucleotide Achieves Broad Biodistribution in the Brain and Ameliorates Angelman Syndrome Phenotype in Mice

Wan Du, MD, PhD | April 11, 2024

Read our monthly summary of a Molecular Therapy article from the April issue of The Vector.

Molecular Therapy

Read Full Story

FDA Hosts Third Installment of CGT Science Series on CMC Guidance

Watch now! | April 11, 2024

Watch this virtual event, as well as past installments of this series, on our YouTube channel.

Policy & Advocacy

Read Full Story

Society Responds to FDA’s Potency Assurance for Cellular and Gene Therapy Products

Margarita L. Valdez Martínez  | April 11, 2024

Potency assays are a key part of product development. ASGCT believes that addressing the overarching concerns with FDA’s outlined potency assurance strategy through these comments will enhance the value of the final guidance document to assist CGT product developers as they address product potency. 

Policy & Advocacy

Read Full Story